血管内碎石术治疗下肢动脉钙化狭窄:Disrupt PAD III 研究初步分析
Disrupt PAD III 观察性研究评估外周血管内碎石术(IVL)治疗多节段钙化外周动脉疾病(PAD)的真实世界表现,纳入 200 例患者共 220 处靶病变。术后平均即刻管腔获得 3.4 mm,最终平均残余狭窄 23.6%,血管造影并发症罕见,无急性闭塞、远端栓塞、无复流或血栓事件。
要点
- IVL 治疗严重钙化下肢动脉狭窄术后残余狭窄低、即刻管腔获得高。
- 真实世界中 IVL 更多与其他球囊技术联用(53.8%),较少联用斑块旋切或支架。
- 尽管病变复杂,IVL 相关血管造影并发症发生率低。
核心结论
- 外周 IVL 用于真实世界严重钙化狭窄性 PAD 显示低残余狭窄、高即刻管腔获得和低并发症率。
研究设计与样本
- Disrupt PAD III 观察性研究为前瞻性、非随机、多中心、单臂观察性研究,评估 Shockwave 外周 IVL 系统的急性安全性和有效性。
- 入组标准为间歇性跛行或慢性肢体威胁性缺血伴中度或重度动脉钙化。
主要发现
- 220 处靶病变中,IVL 更多与其他球囊技术联用(53.8%),联用斑块旋切和支架的比例分别为 19.8% 和 29.9%。
- 术后平均即刻管腔获得 3.4 mm,最终平均残余狭窄 23.6%。
- 血管造影并发症罕见,仅 2 例 D 型夹层和 1 例药物涂层球囊扩张后穿孔(与 IVL 操作无关)。
- 无急性闭塞、远端栓塞、无复流或血栓事件。
临床怎么用
- 对于中度或重度钙化的下肢动脉狭窄,可考虑使用外周 IVL 以获得良好的即刻管腔结果。
- 真实世界中 IVL 常与其他球囊技术联合使用,需根据病变特点选择联合策略。
局限性
- 本研究为非随机单臂观察性研究,随访仅至出院,缺乏长期结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To evaluate the performance of peripheral intravascular lithotripsy (IVL) in a real-world setting during endovascular treatment of multilevel calcified peripheral artery disease (PAD). Materials and Methods: The Disrupt PAD III Observational Study (ClinicalTrials.gov identifier NCT02923193) is a prospective, nonrandomized, multicenter, single-arm observational study assessing the acute safety and effectiveness of the Shockwave Peripheral IVL System for the treatment of calcified, stenotic lower limb arteries. Patients were eligible if they had claudication or chronic limb-threatening ischemia and moderate or severe arterial calcification. Between November 2017 and August 2018, 200 patients (mean age 72.5±8.7 years; 148 men) were enrolled across 18 sites and followed through hospital discharge. Results: In the 220 target lesions, IVL was more commonly used in combination with other balloon-based technologies (53.8%) and less often with concomitant atherectomy or stenting (19.8% and 29.9%, respectively). There was a 3.4-mm average acute gain at the end of procedure; the final mean residual stenosis was 23.6%. Angiographic complications were rare, with only 2 type D dissections and a single perforation following drug-coated balloon inflation (unrelated to the IVL procedure). There was no abrupt closure, distal embolization, no reflow, or thrombotic event. Conclusion: Use of peripheral IVL to treat severely calcified, stenotic PAD in a real-world study demonstrated low residual stenosis, high acute gain, and a low rate of complications despite the complexity of disease.
引用
- Adams G, Shammas N, Mangalmurti S, et al. Intravascular Lithotripsy for Treatment of Calcified Lower Extremity Arterial Stenosis: Initial Analysis of the Disrupt PAD III Study. J Endovasc Ther. 2020. PMID: 32242768. doi:10.1177/1526602820914598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。